TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) has provided an announcement.
Sihuan Pharmaceutical Holdings Group Ltd. announced a share repurchase of 10 million shares, representing approximately 0.1089% of its total issued shares, at an average price of HK$1.5189 per share. This strategic move aligns with the company’s goal of enhancing shareholder value and reflects confidence in its future growth, particularly in its expanding medical aesthetics and innovative pharmaceuticals businesses. The company has seen significant growth in its medical aesthetics segment, with a revenue increase of 81% year-on-year, and has launched several new products, which are expected to drive future revenue and profit growth.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd., founded in 2001 and listed on the Main Board of the Stock Exchange in 2010, is an international medical aesthetics and biopharmaceutical company. The company is driven by innovation with a strong research and development platform, a diverse global product pipeline, and an efficient production and sales system. It focuses on becoming a leading entity in China’s medical aesthetics and biopharmaceutical sectors.
Average Trading Volume: 81,615,751
Technical Sentiment Signal: Buy
Current Market Cap: HK$14.93B
Find detailed analytics on 0460 stock on TipRanks’ Stock Analysis page.